Literature DB >> 2941841

Tumor growth and evasion of immune destruction: UV-induced tumors as a model.

C A Mullen, H Schreiber.   

Abstract

A number of complex interrelating mechanisms contributing to progressive growth of an immunogenic tumor and its evasion of immune destruction are exemplified in the model of the UV-induced tumor 1591 (fig. 3). The effects of (i) carcinogen-induced immune suppression, (ii) age-related changes in immune competence, (iii) generation and immunoselection of tumor cell variants which do not express target tumor antigen and (iv) tumor-induced immune suppression have been documented. The findings may help to assess the problems and the possibilities of immunotherapy of cancer. The problems reside in the many avenues of escape available to the tumor. The possibilities for immunotherapy derive from the fact that progressively growing tumors may still retain immunogenic antigens and therefore be susceptible to immune attack.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2941841     DOI: 10.1007/bf02918734

Source DB:  PubMed          Journal:  Surv Immunol Res        ISSN: 0252-9564


  16 in total

1.  Immunoregulation by ultraviolet light-III. Enhancement of suppressor cell activity in older animals.

Authors:  C W Spellman; R A Daynes
Journal:  Exp Gerontol       Date:  1978       Impact factor: 4.032

2.  Antigenicity of murine skin tumors induced by ultraviolet light.

Authors:  M L Kripke
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

3.  Ultraviolet light induced murine suppressor lymphocytes dictate specificity of anti-ultraviolet tumor immune responses.

Authors:  C W Spellman; R A Daynes
Journal:  Cell Immunol       Date:  1978-06       Impact factor: 4.868

4.  Malignant growth in the normal host after variant selection in vitro with cytolytic T-cell lines.

Authors:  R D Wortzel; J L Urban; H Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

5.  Multiple tumour-specific antigens expressed on a single tumour cell.

Authors:  R D Wortzel; C Philipps; H Schreiber
Journal:  Nature       Date:  1983 Jul 14-20       Impact factor: 49.962

6.  Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor: antigenic dissection with cytolytic T cell clones.

Authors:  R D Wortzel; J L Urban; C Philipps; F W Fitch; H Schreiber
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

7.  Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation.

Authors:  J L Urban; J M Holland; M L Kripke; H Schreiber
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

8.  Multiple cancers. Tumor burden permits the outgrowth of other cancers.

Authors:  C A Mullen; J L Urban; C Van Waes; D A Rowley; H Schreiber
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

9.  Loss of tumor-specific and idiotype-specific immunity with age.

Authors:  P M Flood; J L Urban; M L Kripke; H Schreiber
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

10.  Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity.

Authors:  J L Urban; H Schreiber
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.